A Cure for Alzheimer’s disease? – CEO of Leucadia Therapeutics Doug Ethell -Learning with Lowell 176
Podcast: Play in new window | Download (Duration: 1:22:00 — 112.6MB) | Embed
Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | Podcast Index | TuneIn | RSS | More
Doug Ethell is the founder and CEO of Leucadia Therapeutics, a pre-clinical stage company developing an early diagnostic for Alzheimer’s disease and a therapeutic device to stop that disorder in its earliest stages.